Unknown

Dataset Information

0

In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs.

ABSTRACT: Rational drug design implies usage of molecular modeling techniques such as pharmacophore modeling, molecular dynamics, virtual screening, and molecular docking to explain the activity of biomolecules, define molecular determinants for interaction with the drug target, and design more efficient drug candidates. Kinases play an essential role in cell function and therefore are extensively studied targets in drug design and discovery. Kinase inhibitors are clinically very important and widely used antineoplastic drugs. In this review, computational methods used in rational drug design of kinase inhibitors are discussed and compared, considering some representative case studies.

SUBMITTER: Gagic Z 

PROVIDER: S-EPMC6960140 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

<i>In silico</i> Methods for Design of Kinase Inhibitors as Anticancer Drugs.

Gagic Zarko Z   Ruzic Dusan D   Djokovic Nemanja N   Djikic Teodora T   Nikolic Katarina K  

Frontiers in chemistry 20200108

Rational drug design implies usage of molecular modeling techniques such as pharmacophore modeling, molecular dynamics, virtual screening, and molecular docking to explain the activity of biomolecules, define molecular determinants for interaction with the drug target, and design more efficient drug candidates. Kinases play an essential role in cell function and therefore are extensively studied targets in drug design and discovery. Kinase inhibitors are clinically very important and widely used  ...[more]

Similar Datasets

Unknown CDK7 inhibitors as anticancer drugs.
| S-EPMC7497306 | biostudies-literature
Unknown Cyclin-dependent kinase inhibitors as marketed anticancer drugs: where are we now? A short survey.
| S-EPMC6271685 | biostudies-other
Unknown Repurposing Drugs by In Silico Methods to Target BCR Kinase Domain in Chronic Myeloid Leukemia.
| S-EPMC7063026 | biostudies-literature
Unknown Structure-based design, discovery and development of checkpoint kinase inhibitors as potential anticancer therapies.
| S-EPMC3998639 | biostudies-literature
Unknown Design, Synthesis and Docking Studies of Novel Macrocyclic Pentapeptides as Anticancer Multi-Targeted Kinase Inhibitors.
| S-EPMC6222410 | biostudies-literature
Unknown Application of computational methods for the design of BACE-1 inhibitors: validation of in silico modelling.
| S-EPMC3975444 | biostudies-literature
Unknown Descriptors of Cytochrome Inhibitors and Useful Machine Learning Based Methods for the Design of Safer Drugs.
| S-EPMC8156202 | biostudies-literature
Unknown Cyclin-Dependent Kinase Inhibitors as Anticancer Therapeutics.
| S-EPMC4613943 | biostudies-literature
Unknown In silico design and optimization of selective membranolytic anticancer peptides.
| S-EPMC6677754 | biostudies-literature
Unknown Alignment independent 3D-QSAR, quantum calculations and molecular docking of Mer specific tyrosine kinase inhibitors as anticancer drugs.
| S-EPMC4792907 | biostudies-literature